6,000 Shares in CVS Health Co. (NYSE:CVS) Bought by St. Clair Advisors LLC

St. Clair Advisors LLC acquired a new position in shares of CVS Health Co. (NYSE:CVS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 6,000 shares of the pharmacy operator's stock, valued at approximately $269,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Stonebridge Financial Group LLC bought a new position in CVS Health in the fourth quarter valued at $28,000. Hopwood Financial Services Inc. bought a new position in CVS Health in the fourth quarter valued at $29,000. Financial Perspectives Inc grew its position in CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after purchasing an additional 466 shares in the last quarter. MidAtlantic Capital Management Inc. grew its position in CVS Health by 112.1% in the fourth quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after purchasing an additional 437 shares in the last quarter. Finally, Compass Planning Associates Inc bought a new position in CVS Health in the fourth quarter valued at $37,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CVS. Leerink Partnrs raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 12th. Edward Jones raised shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. Royal Bank of Canada lifted their target price on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Barclays upped their price target on shares of CVS Health from $73.00 to $82.00 and gave the company an "overweight" rating in a research note on Friday, May 2nd. Finally, Cantor Fitzgerald upgraded shares of CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and an average price target of $74.94.

Insider Buying and Selling at CVS Health

In other news, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This trade represents a 47.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.22% of the company's stock.

CVS Health Stock Performance

Shares of CVS traded down $1.95 during mid-day trading on Thursday, hitting $60.16. 10,041,157 shares of the company's stock were exchanged, compared to its average volume of 11,371,746. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $72.51. The stock's 50-day simple moving average is $66.41 and its 200-day simple moving average is $59.34. The firm has a market cap of $76.10 billion, a price-to-earnings ratio of 16.44, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter last year, the business posted $1.31 EPS. The firm's revenue for the quarter was up 7.0% on a year-over-year basis. On average, equities research analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.42%. CVS Health's dividend payout ratio is currently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.